Sterna Biologicals
Marburg
About Sterna Biologicals
The immune system reacts against parasitic infection and environmental substances like allergens with a type-2 response. While per se a beneficial and protective mechanism, millions of individuals are compromised by a dysregulation of type-2 immunity, suffering from chronic inflammatory conditions like asthma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $25.4M
- Last round: Series Unknown (Aug 2022)
- Website: sterna-biologicals.com
- Phone: +49 (0)6421 9830050
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/sterna-biologicals-142196 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.